- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 1.53 | 10.13 | 7.65 | 5.46 | -15.57 | 3.96 | N/A | - | ||
| 2026/3 | 1.39 | 34.23 | -22.89 | 3.93 | -22.12 | 3.93 | 1.46 | - | ||
| 2026/2 | 1.04 | -31.08 | -40.31 | 2.54 | -21.69 | 4.47 | 1.28 | - | ||
| 2026/1 | 1.5 | -21.91 | -0.24 | 1.5 | -0.24 | 4.32 | 1.33 | - | ||
| 2025/12 | 1.93 | 116.12 | 14.87 | 17.75 | -22.38 | 4.01 | 1.5 | - | ||
| 2025/11 | 0.89 | -25.08 | -45.56 | 15.82 | -25.33 | 3.91 | 1.54 | - | ||
| 2025/10 | 1.19 | -34.84 | -25.19 | 14.93 | -23.64 | 4.26 | 1.41 | - | ||
| 2025/9 | 1.83 | 46.62 | -21.08 | 13.74 | -23.5 | 4.84 | 1.44 | - | ||
| 2025/8 | 1.25 | -29.57 | -33.06 | 11.91 | -23.86 | 4.31 | 1.62 | - | ||
| 2025/7 | 1.77 | 36.25 | -23.33 | 10.67 | -22.62 | 4.2 | 1.66 | - | ||
| 2025/6 | 1.3 | 14.86 | -34.58 | 8.9 | -22.47 | 3.85 | 1.91 | - | ||
| 2025/5 | 1.13 | -20.63 | -44.09 | 7.6 | -19.95 | 4.36 | 1.69 | - | ||
| 2025/4 | 1.42 | -21.11 | -31.34 | 6.47 | -13.42 | 4.96 | 1.48 | - | ||
| 2025/3 | 1.8 | 3.9 | -0.48 | 5.05 | -6.54 | 5.05 | 1.43 | - | ||
| 2025/2 | 1.74 | 15.18 | 5.39 | 3.24 | -9.6 | 4.92 | 1.47 | - | ||
| 2025/1 | 1.51 | -10.08 | -22.33 | 1.51 | -22.33 | 4.82 | 1.5 | - | ||
| 2024/12 | 1.68 | 2.41 | 1.71 | 22.87 | 4.62 | 4.9 | 1.58 | - | ||
| 2024/11 | 1.64 | 2.95 | -36.86 | 21.19 | 4.86 | 5.54 | 1.4 | - | ||
| 2024/10 | 1.59 | -31.26 | -2.87 | 19.55 | 11.0 | 5.76 | 1.35 | - | ||
| 2024/9 | 2.31 | 24.36 | 12.27 | 17.96 | 12.42 | 6.48 | 1.17 | - | ||
| 2024/8 | 1.86 | -19.34 | 11.1 | 15.65 | 12.44 | 6.15 | 1.23 | - | ||
| 2024/7 | 2.31 | 16.26 | 54.83 | 13.79 | 12.63 | 6.31 | 1.2 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低，因而本月營業收入淨額相較成長54.83%。 | ||
| 2024/6 | 1.98 | -1.83 | 59.48 | 11.48 | 6.78 | 6.08 | 1.32 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低，因而本月營業收入淨額相較成長59.48%。 | ||
| 2024/5 | 2.02 | -2.52 | -2.79 | 9.5 | -0.1 | 5.91 | 1.35 | - | ||
| 2024/4 | 2.07 | 14.33 | 23.88 | 7.48 | 0.64 | 5.53 | 1.45 | - | ||
| 2024/3 | 1.81 | 10.04 | -19.75 | 5.4 | -6.11 | 5.4 | N/A | - | ||
| 2024/2 | 1.65 | -15.12 | -9.91 | 3.59 | 2.7 | 5.24 | N/A | - | ||
| 2024/1 | 1.94 | 17.76 | 16.57 | 1.94 | 16.57 | 6.18 | N/A | - | ||
| 2023/12 | 1.65 | -36.43 | -36.92 | 21.86 | -27.35 | 5.88 | N/A | - | ||
| 2023/11 | 2.59 | 58.37 | 5.32 | 20.21 | -26.44 | 6.29 | N/A | - | ||
| 2023/10 | 1.64 | -20.54 | -16.92 | 17.61 | -29.56 | 5.37 | N/A | - | ||
| 2023/9 | 2.06 | 23.07 | 5.06 | 15.98 | -30.64 | 5.23 | N/A | - | ||
| 2023/8 | 1.67 | 12.4 | -25.78 | 13.92 | -33.97 | 4.41 | N/A | - | ||
| 2023/7 | 1.49 | 19.75 | -35.27 | 12.24 | -34.95 | 4.81 | N/A | - | ||
| 2023/6 | 1.24 | -40.17 | -39.45 | 10.75 | -34.91 | 5.0 | N/A | - | ||
| 2023/5 | 2.08 | 24.23 | -36.53 | 9.51 | -34.26 | 6.01 | N/A | - | ||
| 2023/4 | 1.67 | -25.94 | -48.0 | 7.43 | -33.6 | 5.76 | N/A | - | ||
| 2023/3 | 2.26 | 23.53 | -34.05 | 5.75 | -27.78 | 5.75 | N/A | - | ||
| 2023/2 | 1.83 | 9.83 | 3.94 | 3.49 | -23.04 | 6.11 | N/A | - | ||
| 2023/1 | 1.67 | -36.28 | -40.12 | 1.67 | -40.12 | 6.74 | N/A | - | ||
| 2022/12 | 2.61 | 6.15 | 0.01 | 30.09 | 5.53 | 7.05 | N/A | - | ||
| 2022/11 | 2.46 | 24.92 | -19.59 | 27.47 | 6.09 | 6.4 | N/A | - | ||
| 2022/10 | 1.97 | 0.48 | -26.92 | 25.01 | 9.54 | 6.19 | N/A | - | ||
| 2022/9 | 1.96 | -13.06 | -12.99 | 23.04 | 14.42 | 6.52 | N/A | - | ||
| 2022/8 | 2.26 | -1.96 | 16.16 | 21.08 | 17.88 | 6.61 | N/A | - | ||
| 2022/7 | 2.3 | 12.02 | 27.54 | 18.82 | 18.09 | 7.63 | N/A | - | ||
| 2022/6 | 2.05 | -37.29 | -15.6 | 16.52 | 16.89 | 8.55 | N/A | - | ||
| 2022/5 | 3.28 | 1.78 | 42.14 | 14.46 | 23.65 | 9.92 | N/A | - | ||
| 2022/4 | 3.22 | -6.07 | 51.45 | 11.19 | 19.11 | 8.41 | N/A | 主要為特用化學品中除受匯率影響外，抗氧化劑及阻燃劑訂價調整或出貨增加，故本月營業收入淨額較去年同期增加51.45%。 | ||
| 2022/3 | 3.43 | 94.73 | 23.03 | 7.97 | 9.65 | 7.97 | N/A | - | ||
| 2022/2 | 1.76 | -36.73 | -2.38 | 4.54 | 1.34 | 7.16 | N/A | - | ||
| 2022/1 | 2.78 | 6.42 | 3.85 | 2.78 | 3.85 | 8.46 | N/A | - | ||
| 2021/12 | 2.61 | -14.65 | 29.6 | 28.51 | 3.56 | 8.37 | N/A | - | ||
| 2021/11 | 3.06 | 13.54 | 29.26 | 25.89 | 1.5 | 8.01 | N/A | - | ||
| 2021/10 | 2.7 | 19.62 | 39.28 | 22.83 | -1.34 | 6.89 | N/A | - | ||
| 2021/9 | 2.25 | 16.07 | 12.01 | 20.13 | -5.05 | 6.0 | N/A | - | ||
| 2021/8 | 1.94 | 7.63 | -2.69 | 17.88 | -6.84 | 6.18 | N/A | - | ||
| 2021/7 | 1.8 | -25.87 | -18.11 | 15.94 | -7.32 | 6.54 | N/A | - | ||
| 2021/6 | 2.43 | 5.62 | 10.98 | 14.13 | -5.73 | 0.0 | N/A | - | ||
| 2021/5 | 2.3 | 8.44 | 8.8 | 11.7 | -8.6 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 1.5 | 2025/1 | 1.51 | 2024/1 | 1.94 | 2023/1 | 1.67 | 2022/1 | 2.78 |
| 2026/2 | 1.04 | 2025/2 | 1.74 | 2024/2 | 1.65 | 2023/2 | 1.83 | 2022/2 | 1.76 |
| 2026/3 | 1.39 | 2025/3 | 1.8 | 2024/3 | 1.81 | 2023/3 | 2.26 | 2022/3 | 3.43 |
| 2026/4 | 1.53 | 2025/4 | 1.42 | 2024/4 | 2.07 | 2023/4 | 1.67 | 2022/4 | 3.22 |
| N/A | N/A | 2025/5 | 1.13 | 2024/5 | 2.02 | 2023/5 | 2.08 | 2022/5 | 3.28 |
| N/A | N/A | 2025/6 | 1.3 | 2024/6 | 1.98 | 2023/6 | 1.24 | 2022/6 | 2.05 |
| N/A | N/A | 2025/7 | 1.77 | 2024/7 | 2.31 | 2023/7 | 1.49 | 2022/7 | 2.3 |
| N/A | N/A | 2025/8 | 1.25 | 2024/8 | 1.86 | 2023/8 | 1.67 | 2022/8 | 2.26 |
| N/A | N/A | 2025/9 | 1.83 | 2024/9 | 2.31 | 2023/9 | 2.06 | 2022/9 | 1.96 |
| N/A | N/A | 2025/10 | 1.19 | 2024/10 | 1.59 | 2023/10 | 1.64 | 2022/10 | 1.97 |
| N/A | N/A | 2025/11 | 0.89 | 2024/11 | 1.64 | 2023/11 | 2.59 | 2022/11 | 2.46 |
| N/A | N/A | 2025/12 | 1.93 | 2024/12 | 1.68 | 2023/12 | 1.65 | 2022/12 | 2.61 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.51 | -34.62 | 37.84 |
| 25Q4 (7) | 0.78 | 69.57 | 7700.0 |
| 25Q3 (6) | 0.46 | 76.92 | 1433.33 |
| 25Q2 (5) | 0.26 | -29.73 | 271.43 |
| 25Q1 (4) | 0.37 | 3600.0 | 0.0 |
| 24Q4 (3) | 0.01 | -66.67 | 0.0 |
| 24Q3 (2) | 0.03 | -57.14 | 0.0 |
| 24Q2 (1) | 0.07 | 0.0 | 0.0 |
免責聲明
本網站所有資料僅供參考，如使用者依本資料交易發生交易損失需自行負責，本網站對資料內容錯誤﹑更新延誤不負任何責任。